Advisory Services Network’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AUPH
TCM
NMC
Advisory Services Network's AUPH Position: Q2 2026 in Review
Advisory Services Network increased its Aurinia Pharmaceuticals (AUPH) stake by 3.3% in Q2 2026, buying an estimated $33.7K and bringing the position to 65,289 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #965.
Advisory Services Network first reported a position in AUPH in Q1 2019 and has held it in 19 quarters since. The position peaked at $3.12M in Q1 2022. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.
- Advisory Services Network held 65,289 shares of Aurinia Pharmaceuticals worth $1.11M as of Q2 2026.
- Advisory Services Network bought 2,111 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $33.7K.
- Aurinia Pharmaceuticals made up 0.01% of Advisory Services Network's portfolio in Q2 2026, its #965 holding.
- Advisory Services Network first reported a position in Aurinia Pharmaceuticals in Q1 2019 and has held it in 19 quarters since.
- Advisory Services Network's Aurinia Pharmaceuticals position peaked at $3.12M in Q1 2022.
- 283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.
Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.